{
  "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
  "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
  "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
  "authorId": "alkermes",
  "authorName": "Mural Oncology",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 29,
  "pageCount": 37,
  "prevPage": 28,
  "nextPage": 30,
  "slideType": "before_after",
  "function": "propose_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Uses a before-after-bridge framework to illustrate the mechanism of action for the therapeutic candidate.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/29",
  "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
  "deckJsonHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e.json",
  "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-29",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.32,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "callout",
      "text": "Challenge to IL-18",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0c6b17bb-7ef7-4e22-8387-f424dfa83dba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.56,
        "x": 0.39,
        "y": 0.25
      },
      "kind": "callout",
      "text": "Mural Solution: design IL-18 variant resistant to IL-18BP",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5df25c4c-058f-4237-92d8-2d2ffe95216b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.48,
        "w": 0.63,
        "x": 0.09,
        "y": 0.38
      },
      "kind": "image",
      "text": "Diagram showing IL-18 inhibited by IL-18BP vs engineered IL-18v avoiding IL-18BP",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cb30dcd5-b1fd-4d3c-a7db-66cac7c50f3e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.65,
        "y": 0.52
      },
      "kind": "list",
      "text": "1. Resist IL-18 neutralization by immune checkpoint IL-18BP\n2. Retain and optimize IL-18 activity",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c992cc6-3324-486f-a042-975dc5de3ea0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.12,
        "x": 0.28,
        "y": 0.78
      },
      "kind": "source-note",
      "text": "Internal expertise in protein engineering",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "132623aa-87dc-475d-af99-27755169409e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.88,
        "x": 0.06,
        "y": 0.06
      },
      "kind": "title",
      "text": "Mural Oncology IL-18 Engineering: Resist IL-18BP Checkpoint to Unleash the Therapeutic Potential of IL-18",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8ff9aa7a-b1ce-409b-9ffd-0914c304f094",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "before-after-bridge",
      "slug": null,
      "matchId": "5193beec-9776-47a4-82df-c2cb15f644eb",
      "evidence": "Visual comparison of current challenge (IL-18 inhibition) and proposed solution (IL-18v) with a bridge arrow.",
      "confidence": 1
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}